CELLULAR MATRIX Trademark

Trademark Overview


On Monday, October 16, 2017, a trademark application was filed for CELLULAR MATRIX with the United States Patent and Trademark Office. The USPTO has given the CELLULAR MATRIX trademark a serial number of 87646517. The federal status of this trademark filing is REGISTERED as of Tuesday, July 13, 2021. This trademark is owned by RegenLab USA LLC. The CELLULAR MATRIX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; products and preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes;...

Medical devices, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and othe...
cellular matrix

General Information


Serial Number87646517
Word MarkCELLULAR MATRIX
Filing DateMonday, October 16, 2017
Status700 - REGISTERED
Status DateTuesday, July 13, 2021
Registration Number6420153
Registration DateTuesday, July 13, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; products and preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use
NOT AVAILABLE"CELLULAR"
Goods and ServicesMedical devices, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments, namely, tubes, containers, syringes, needles, for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology, mesotherapy, cardiovascular, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical purposes; suture material; cases fitted for medical instruments; receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; containers specially adapted for storing tissue and biological samples for medical purposes; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2017
Primary Code005
First Use Anywhere DateSaturday, May 1, 2021
First Use In Commerce DateSaturday, May 1, 2021

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2017
Primary Code010
First Use Anywhere DateSaturday, May 1, 2021
First Use In Commerce DateSaturday, May 1, 2021

Trademark Owner History


Party NameRegenLab USA LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressJersey City, NJ 07302

Party NameRegenLab USA LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBrooklyn, NY 11220

Party NameRegenLab USA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 100222511

Trademark Events


Event DateEvent Description
Thursday, February 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 19, 2017NEW APPLICATION ENTERED
Wednesday, October 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 25, 2018ASSIGNED TO EXAMINER
Thursday, February 1, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, February 1, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, February 1, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, February 1, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 14, 2018SOU EXTENSION 1 FILED
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 1, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 1, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 14, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, November 14, 2018SOU EXTENSION 1 GRANTED
Friday, November 15, 2019SOU EXTENSION 3 FILED
Friday, November 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 21, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 21, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 7, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, May 7, 2019SOU EXTENSION 2 FILED
Tuesday, May 7, 2019SOU EXTENSION 2 GRANTED
Thursday, May 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2019TEAS PETITION TO REVIVE RECEIVED
Monday, December 2, 2019SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, May 15, 2020SOU EXTENSION 4 FILED
Monday, December 2, 2019PETITION TO REVIVE-GRANTED
Tuesday, December 3, 2019NOTICE OF REVIVAL - E-MAILED
Friday, January 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 10, 2020SOU EXTENSION 3 GRANTED
Saturday, January 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 15, 2020ABANDONMENT - NO USE STATEMENT FILED
Monday, June 15, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, June 16, 2020PETITION TO REVIVE-GRANTED
Tuesday, June 16, 2020TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 16, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, June 16, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, June 18, 2020SOU EXTENSION 4 GRANTED
Friday, June 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 9, 2020SOU TEAS EXTENSION RECEIVED
Monday, November 9, 2020SOU EXTENSION 5 FILED
Thursday, November 12, 2020SOU EXTENSION 5 GRANTED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 14, 2021TEAS STATEMENT OF USE RECEIVED
Saturday, June 5, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 14, 2021USE AMENDMENT FILED
Monday, May 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, June 4, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 13, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 5, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED